OPTIMIZING ANTIEMESIS IN CANCER-CHEMOTHERAPY - EFFICACY OF CONTINUOUS VERSUS INTERMITTENT INFUSION OF HIGH-DOSE METOCLOPRAMIDE IN EMESIS INDUCED BY CISPLATIN

被引：49
|
作者：
WARRINGTON, PS
ALLAN, SG
CORNBLEET, MA
MACPHERSON, JS
SMYTH, JF
LEONARD, RCF
机构：
来源：
BRITISH MEDICAL JOURNAL | 1986年 / 293卷 / 6558期
关键词：
D O I：
10.1136/bmj.293.6558.1334
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1334 / 1337
页数：4
相关论文
共 50 条
  • [1] CONTINUOUS VERSUS INTERMITTENT INFUSION OF HIGH-DOSE METOCLOPRAMIDE IN PREVENTION OF CISPLATIN-INDUCED EMESIS
    EGROS, F
    DUFOUR, A
    CAZOR, JL
    [J]. LANCET, 1992, 340 (8819): : 619 - 619
  • [2] A RANDOMIZED TRIAL OF HIGH-DOSE BOLUS METOCLOPRAMIDE VERSUS LOW-DOSE CONTINUOUS INFUSION METOCLOPRAMIDE IN THE PREVENTION OF CISPLATIN-INDUCED EMESIS
    DANA, BW
    MCDERMOTT, M
    EVERTS, E
    ABDULHAY, G
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1987, 10 (03): : 253 - 256
  • [3] CONTINUOUS-INFUSION VERSUS INTERMITTENT SHORT INFUSION OF METOCLOPRAMIDE FOR CISPLATIN-INDUCED ACUTE EMESIS
    SAITO, H
    SHIMOKATA, K
    YAMORI, S
    KAJITA, M
    NIIMI, T
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (05): : 422 - 426
  • [4] CONTINUOUS INFUSION OF HIGH-DOSE METOCLOPRAMIDE FOR THE PREVENTION OF NAUSEA AND VOMITING IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY
    JOSS, RA
    GALEAZZI, RL
    BRUNNER, KW
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 25 (01) : 35 - 39
  • [5] METOCLOPRAMIDE KINETICS AT HIGH-DOSE INFUSION RATES FOR PREVENTION OF CISPLATIN-INDUCED EMESIS
    SALLER, R
    HELLENBRECHT, D
    BRIEMANN, L
    HELLSTERN, A
    HESS, H
    MITROU, P
    HODGSON, M
    ACHTERT, G
    BROCKMANN, P
    HAUSLEITER, HJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 37 (01) : 43 - 47
  • [6] HIGH-DOSE DEXAMETHASONE AND HIGH-DOSE METOCLOPRAMIDE VERSUS HIGH-DOSE DEXAMETHASONE AND SULPIRIDE IN THE MANAGEMENT OF CISPLATIN-INDUCED EMESIS
    ROSENBLATT, E
    LEV, LM
    ROBINSON, E
    [J]. ONCOLOGY, 1988, 45 (04) : 297 - 299
  • [7] COMPARISON OF INTERMITTENT VERSUS CONTINUOUS INFUSION METOCLOPRAMIDE IN CONTROL OF ACUTE NAUSEA INDUCED BY CISPLATIN CHEMOTHERAPY
    NAVARI, RM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (07) : 943 - 946
  • [8] HIGH-DOSE METOCLOPRAMIDE AND CHLORPROMAZINE IN THE TREATMENT OF CISPLATIN-INDUCED EMESIS
    AASEBO, U
    SLORDAL, L
    PRYTZ, PS
    AARBAKKE, J
    [J]. PHARMACOLOGY & TOXICOLOGY, 1987, 60 (05): : 337 - 339
  • [9] CONTINUOUS INFUSION OF HIGH-DOSE METOCLOPRAMIDE - COMPARISON OF PHARMACOKINETICALLY ADJUSTED AND STANDARD DOSES FOR THE CONTROL OF CISPLATIN-INDUCED ACUTE EMESIS
    BRECHOT, JM
    DUPEYRON, JP
    DELATTRE, C
    CHASTANG, C
    LAABAN, JP
    ROCHEMAURE, J
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (03) : 283 - 286
  • [10] CONTINUOUS INFUSION OF METOCLOPRAMIDE FOR PREVENTION OF CHEMOTHERAPY-INDUCED EMESIS
    AGOSTINUCCI, WA
    GANNON, RH
    SCHAUER, PK
    WALTERS, JK
    [J]. CLINICAL PHARMACY, 1986, 5 (02): : 150 - 153
12345